Shares of Akari Therapeutics, Plc (NASDAQ:AKTX – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.40 and traded as low as $1.47. Akari Therapeutics shares last traded at $1.52, with a volume of 20,155 shares traded. Wall Street Analysts Forecast Growth […]
StockNews com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Akari Therapeutics, Plc (NASDAQ:AKTX – Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 10,500 shares, an increase of 75.0% from the March 15th total of 6,000 shares. Approximately 0.2% of the shares of the stock are […]
StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note published on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance Akari Therapeutics stock opened at $1.18 on Monday. Akari Therapeutics has a 1 year low of $1.10 and a 1 […]
Akari Therapeutics, Plc (NASDAQ:AKTX – Get Free Report) saw a large decline in short interest in January. As of January 31st, there was short interest totalling 1,900 shares, a decline of 66.7% from the January 15th total of 5,700 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average […]